Current Clinical Trials

Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01458574
Title: A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS A MAINTENANCE THERAPY IN SUBJECTS WITH ULCERATIVE COLITIS
Department: Cardiology
Diagnosis: Miscellaneous
Sub-Investigator(s):
Sponsor: Synageva
Indentifier #: NCT02112994
Title: A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency
Department: Oncology
Diagnosis: Breast- Metastatic
Principal Investigator: Lynch MD, Cynthia A.
Sponsor: Astra Zeneca
Indentifier #: NCT02000622
Title: D0819C00003, A Phase III, Open Label, Randomized, Controlled, Multi-centre Study to assess the efficacy and safety of Olaparib Monotherapy versus Physician's Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients with germline BRCA1/2 Mutations
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: McDonald M.D., Thomas
Sponsor: Ortho-McNeil Janssen Scie
Indentifier #: none
Title: Limited access protocol for the use of oral cisapride in the treatment of refractory gastroesophogeal reflux disease and other gastrointestinal motility disorders. CIS-USA-154
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01470612
Title: A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Department: Cardiology
Diagnosis: Cardiac - Coronary Artery Disease
Principal Investigator: Kaluski MD, Edo
Sub-Investigator(s):
Sponsor: Astra Zeneca
Indentifier #: NCT01866904
Title: TIGRIS: Long-Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease in post myocardial infarction patients
Department: Oncology
Diagnosis: Breast- Adjuvant
Principal Investigator: Lynch MD, Cynthia A.
Sponsor: AbbVie
Indentifier #: NCT02032277
Title: M14-011, A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study Evaluating Safety and Efficacy of the Addition of Veliparib Plus Carboplatin Versus the Addition of Carboplatin to Standard Neoadjuvant Chemotherapy Versus Standard Neoadjuvant Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer (TNBC)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: Srivatana M.D., Ukorn
Sponsor: Cubist
Indentifier #: NCT01598311
Title: LCD-CDAD-11-06 entitled, "A RANDOMIZED, DOUBLE-BLINDED, ACTIVE-CONTROLLED STUDY OF CB-183,315 IN PATIENTS WITH CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA" CUBIST
Department: Cardiology
Diagnosis: Cardiac - Acute Coronary Syndrome
Sub-Investigator(s):
Sponsor: Sanofi Aventis
Indentifier #: NCT01663402
Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome (Odyssey SA_EFC11570)
Department: Family Practice
Diagnosis: Infectious Disease
Principal Investigator:
Sub-Investigator(s):
Sponsor: Pfizer
Indentifier #: NCT00665561
Title: An International, Multicenter, Prospective Observational Study Of The Safety Of Maraviroc Used With Optimized Background Therapy In Treatment-Experienced HIV-1 Infected Patients